On the Biomedicalization of Alcoholism
de Jong, Johan
de Wert, Guido
Theoretical Medicine and Bioethics 2009; 30(4): 311-321
The shift in the prevailing view of alcoholism from a moral paradigm towards a biomedical paradigm is often characterized as a form of biomedicalization. We will examine and critique three reasons offered for the claim that viewing alcoholism as a disease is morally problematic. The first is that the new conceptualization of alcoholism as a chronic brain disease will lead to individualization, e.g., a too narrow focus on the individual person, excluding cultural and social dimensions of alcoholism. The second claim is that biomedicalization will lead to stigmatization and discrimination for both alcoholics and people who are at risk of becoming alcoholics. The third claim is that as a result of the biomedical point of view, the autonomy and responsibility of alcoholics and possibly even persons at risk may be unjustly restricted. Our conclusion is that the claims against the biomedical conceptualization of alcoholism as a chronic brain disease are neither specific nor convincing. Not only do some of these concerns also apply to the traditional moral model; above that they are not strong enough to justify the rejection of the new biomedical model altogether. The focus in the scientific and public debate should not be on some massive "biomedicalization objection" but on the various concerns underlying what is framed in terms of the biomedicalization of alcoholism.
Showing items related by title, author, creator and subject.
de Jong, Antina; Dondorp, Wybo J.; de Die-Smulders, Christine E.M.; Frints, Suzanne G.M.; de Wert, Guido M.W.R. (2010-03)This paper explores the ethical implications of introducing non-invasive prenatal diagnostic tests (NIPD tests) in prenatal screening for foetal abnormalities. NIPD tests are easy and safe and can be performed early in ...
de Jong, Antina; Dondorp, Wybo J; Timmermans, Daniëlle R M; van Lith, Jan M M; de Wert, Guido M W R (2011-10)No consensus exists whether women at increased risk for trisomy 21, 13, and 18 should be offered stand-alone rapid aneuploidy detection (RAD) or karyotyping. In this paper, the ethical implications of a fast, relatively ...